Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases-Reference-Cited by-同舟云学术

Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases

Published:2022-12 Issue: Volume:133 Page:102912
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Renaudineau Yves^ORCID,Sailler Laurent,Abravanel Florence,Izopet Jacques,Delourme Adrien,Biotti Damien,Ciron Jonathan,Treiner Emmanuel,Congy-Jolivet Nicolas,Bost Chloé,Blancher Antoine

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference30 articles.

1. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry;Gianfrancesco;Ann. Rheum. Dis.,2020

2. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases;Larionova;J Transl Autoimmun,2022

3. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study;Furer;Ann. Rheum. Dis.,2021

4. Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases;Arumahandi de Silva;Ann. Rheum. Dis.,2022

5. Antigen specific humoral and cellular immunity following SARS-CoV-2 vaccination in ANCA-associated vasculitis patients receiving B-cell depleting therapy;Marty;Front. Immunol.,2022

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases;Journal of Translational Autoimmunity;2024-06

2. Impact of Immunomodulatory Therapy on COVID-19 Vaccine Response in Patients with Autoimmune Inflammatory Rheumatic Diseases;Vaccines;2024-03-06

3. Infectious Complications of Pulmonary Sarcoidosis;Journal of Clinical Medicine;2024-01-07

4. Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase;Journal of Translational Autoimmunity;2023-12

5. Low performance of interferon gamma release assay Quantiferon-TB gold coupled or not with Pst1/3/lipoglycan humoral detection to predict Mycobacterium tuberculosis complex disease in a low-burden area;Tuberculosis;2023-12